Microbot Medical (NASDAQ:MBOT) Stock Passes Above 200 Day Moving Average – Here’s Why

Microbot Medical Inc. (NASDAQ:MBOT)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.98 and traded as high as $1.01. Microbot Medical shares last traded at $1.00, with a volume of 304,319 shares traded.

Microbot Medical Trading Up 11.0 %

The firm’s 50-day moving average is $0.98 and its 200 day moving average is $0.98. The firm has a market capitalization of $18.79 million, a price-to-earnings ratio of -1.39 and a beta of 1.62.

Hedge Funds Weigh In On Microbot Medical

A hedge fund recently bought a new stake in Microbot Medical stock. Thoroughbred Financial Services LLC bought a new stake in shares of Microbot Medical Inc. (NASDAQ:MBOT) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 52,250 shares of the biotechnology company’s stock, valued at approximately $53,000. Thoroughbred Financial Services LLC owned 0.33% of Microbot Medical as of its most recent filing with the Securities and Exchange Commission. 16.30% of the stock is currently owned by hedge funds and other institutional investors.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.